66
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up

, , , , , , , & show all
Pages 523-528 | Published online: 15 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Hady Saheb, Eric D. Donnenfeld, Kerry D. Solomon, Lilit Voskanyan, David F. Chang, Thomas W. Samuelson, Iqbal Ike K Ahmed & L Jay Katz. (2021) Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma. Current Eye Research 46:2, pages 224-231.
Read now
Koji Nitta, Yutaro Yamada, Satomi Morokado & Kazuhisa Sugiyama. (2020) iStent Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in a Japanese Glaucoma Population. Clinical Ophthalmology 14, pages 3381-3391.
Read now
Colin Clement, Frank Howes, Alexandros S Ioannidis, Michael Shiu, David Manning, Jed Lusthaus, Ridia Lim, Simon E Skalicky & Todd Goodwin. (2020) Two-Year Multicenter Outcomes of iStent inject Trabecular Micro-Bypass Stents Combined with Phacoemulsification in Various Types of Glaucoma and Ocular Hypertension. Clinical Ophthalmology 14, pages 3507-3517.
Read now
Jullia A Rosdahl & Divakar Gupta. (2020) Prospective Studies of Minimally Invasive Glaucoma Surgeries: Systematic Review and Quality Assessment. Clinical Ophthalmology 14, pages 231-243.
Read now
Richard Lindstrom, Steven R Sarkisian, Richard Lewis, John Hovanesian & Lilit Voskanyan. (2020) Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication. Clinical Ophthalmology 14, pages 71-80.
Read now
L Jay Katz, Carl Erb, Amadeu Carceller Guillamet, Antonio M Fea, Lilit Voskanyan, Jane Ellen Giamporcaro & Dana M Hornbeak. (2018) Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes. Clinical Ophthalmology 12, pages 255-262.
Read now

Articles from other publishers (19)

Colin Clement, Frank Howes, Alexandros Ioannidis, Michael Shiu, David Manning, Jed A Lusthaus, Simon E Skalicky & Todd W Goodwin. (2022) Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension. Clinical Ophthalmology Volume 16, pages 2955-2968.
Crossref
Philippe Denis, Christoph Hirneiß, Georges M Durr, Kasu Prasad Reddy, Anita Kamarthy, Ernesto Calvo, Zubair Hussain & Iqbal K Ahmed. (2022) Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. British Journal of Ophthalmology 106:1, pages 65-70.
Crossref
Ali Salimi, Harrison Watt & Paul Harasymowycz. (2021) Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results. Eye and Vision 8:1.
Crossref
Ali Salimi, Mohamed Abu-Nada & Paul Harasymowycz. (2021) Matched Cohort Study of Cataract Surgery With and Without Trabecular Microbypass Stent Implantation in Primary Angle-Closure Glaucoma. American Journal of Ophthalmology 224, pages 310-320.
Crossref
Paul R. Healey, Colin I. Clement, Nathan M. Kerr, Dominic Tilden & Lara Aghajanian. (2021) Standalone iStent Trabecular Micro-bypass Glaucoma Surgery. Journal of Glaucoma Publish Ahead of Print.
Crossref
Raphael Neuhann & Tobias Neuhann. (2020) Second-generation trabecular micro-bypass stent implantation: Retrospective analysis after 12- and 24-month follow-up. Eye and Vision 7:1.
Crossref
John Berdahl, Lilit Voskanyan, Jonathan S. Myers, L. Jay Katz & Thomas W. Samuelson. (2020) iStent inject trabecular micro‐bypass stents with topical prostaglandin as standalone treatment for open‐angle glaucoma: 4‐year outcomes . Clinical & Experimental Ophthalmology 48:6, pages 767-774.
Crossref
Yu-Yen Chen, Yun-Ju Lai, Yung-Feng Yen & Li-Ying Huang. (2020) Use of iStent as a Standalone Operation in Patients with Open-Angle Glaucoma. Journal of Ophthalmology 2020, pages 1-13.
Crossref
David Manning. (2019) Real-world Case Series of iStent or iStent inject Trabecular Micro-Bypass Stents Combined with Cataract Surgery. Ophthalmology and Therapy 8:4, pages 549-561.
Crossref
Ricardo Augusto Paletta Guedes, Daniela Marcelo Gravina, Jonathan Clive Lake, Vanessa Maria Paletta Guedes & Alfredo Chaoubah. (2019) One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center. Advances in Therapy 36:10, pages 2797-2810.
Crossref
Fritz H. Hengerer, Gerd U. Auffarth, Christoffer Riffel & Ina Conrad-Hengerer. (2019) Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study. Advances in Therapy 36:7, pages 1606-1617.
Crossref
Thomas W. Samuelson, Steven R. SarkisianJr.Jr., David M. Lubeck, Michael C. Stiles, Yi-Jing Duh, Eeke A. Romo, Jane Ellen Giamporcaro, Dana M. Hornbeak, L. Jay Katz, William Bartlett, Carlos Buznego, Starck Johnson, Francis A. D'Ambrosio, Doug Dehning, Harvey DuBiner, Raj Goyal, Bret Hughes, Robert E. Marquis, Robert Noecker, Shachar Tauber, Bernard R. Perez, Lawrence Roel, Steven Sarkisian, Steven Silverstein, Steven Day, Kerry Solomon, Farrell Tyson, Steven Vold, Thomas Samuelson, Steven Simmons, Michael Stiles, Quang H. Nguyen, Kent P. Bashford, Brian Flowers, William J. Flynn, Joseph Gira, Constance Okeke, George R. Reiss, Sydney L. Tyson, Greg Parkhurst, John Linn, David Lubeck, Jonathan Solomon, Inder Paul Singh, R. Duncan Johnson, Christopher Lin, Joshua W. Kim, Charles J. Crane & Frank Cotter. (2019) Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. Ophthalmology 126:6, pages 811-821.
Crossref
Robert D. Fechtner, Lilit Voskanyan, Steven D. Vold, Manfred Tetz, Gerd Auffarth, Imran Masood, Leon Au, Albert S. Khouri, Iqbal Ike K. Ahmed & Hady Saheb. (2019) Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle Glaucoma. Ophthalmology Glaucoma 2:3, pages 156-166.
Crossref
Soshian Sarrafpour, Danish Saleh, Samantha Ayoub & Nathan M. Radcliffe. (2019) Micropulse Transscleral Cyclophotocoagulation. Ophthalmology Glaucoma 2:3, pages 167-171.
Crossref
Tobias H. Neuhann, Dana M. Hornbeak, Raphael T. Neuhann & Jane Ellen Giamporcaro. (2019) Long-term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: Five-year outcomes. Journal of Cataract and Refractive Surgery 45:3, pages 312-320.
Crossref
Ricardo Augusto Paletta Guedes, Daniela Marcelo Gravina, Jonathan Clive Lake, Vanessa Maria Paletta Guedes & Alfredo Chaoubah. (2019) Intermediate Results of iStent or iStent inject Implantation Combined with Cataract Surgery in a Real-World Setting: A Longitudinal Retrospective Study. Ophthalmology and Therapy 8:1, pages 87-100.
Crossref
Fritz H. Hengerer, Gerd U. Auffarth, Christoffer Riffel & Ina Conrad-Hengerer. (2018) Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma. Ophthalmology and Therapy 7:2, pages 405-415.
Crossref
Jonathan S. Myers, Imran Masood, Dana M. Hornbeak, Jose I. Belda, Gerd Auffarth, Anselm Jünemann, Jane Ellen Giamporcaro, Jose M. Martinez-de-la-Casa, Iqbal Ike K. Ahmed, Lilit Voskanyan & L. Jay Katz. (2018) Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes. Advances in Therapy 35:3, pages 395-407.
Crossref
John Berdahl, Lilit Voskanyan, Jonathan S Myers, Dana M Hornbeak, Jane Ellen Giamporcaro, L Jay Katz & Thomas W Samuelson. (2017) Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up. Clinical & Experimental Ophthalmology 45:8, pages 797-802.
Crossref